Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Jain

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Blood Cancer Journal|March 12, 2020
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosisTania Jain, Katie L Kunze, Luke Mountjoy, et al.
Research Square|April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan Ling, Jian Zhang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2020
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case reportMuhammad Baraa Hammami, Brian Garibaldi, Pali Shah, et al.
Blood Neoplasia|September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AMLAndrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Blood|April 21, 2023
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemiaAmy E DeZern, Marianna Zahurak, Heather J Symons, et al.
Haematologica|October 4, 2024
Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/ hypomethylating agentsSabine Kayser, Khaled Sanber, Giovanni Marconi, et al.
Annals of Hematology|April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patientsVerónica González-Calle, Abigail Slack, Niamh Keane, et al.
American Journal of Hematology|August 5, 2025
CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR AnalysisSwetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Transplantation and Cellular Therapy|August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation CyclophosphamideKatherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Blood Cancer Journal|March 12, 2020
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosisTania Jain, Katie L Kunze, Luke Mountjoy, et al.
Research Square|April 24, 2023
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblastsIn Young Choi, Jonathan Ling, Jian Zhang, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2020
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case reportMuhammad Baraa Hammami, Brian Garibaldi, Pali Shah, et al.
Blood Neoplasia|September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AMLAndrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Blood|April 21, 2023
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemiaAmy E DeZern, Marianna Zahurak, Heather J Symons, et al.
Haematologica|October 4, 2024
Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/ hypomethylating agentsSabine Kayser, Khaled Sanber, Giovanni Marconi, et al.
Annals of Hematology|April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patientsVerónica González-Calle, Abigail Slack, Niamh Keane, et al.
American Journal of Hematology|August 5, 2025
CD19 Directed CAR T Therapy for Transformed Follicular Lymphoma: A CIBMTR AnalysisSwetha Kambhampati Thiruvengadam, Kwang Woo Ahn, Jinalben Patel, et al.
Research Square|March 30, 2023
Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American CollaborationTania Jain, Hua-Ling Tsai, Hany Elmariah, et al.
Transplantation and Cellular Therapy|August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation CyclophosphamideKatherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.
Pageof 12